chlorpyrifos has been researched along with piperidines in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, SE | 1 |
Darvesh, S; Duysen, EG; Li, B; Lockridge, O | 1 |
Chatterjee, S; Dabral, S; Divya, G; Nanguneri, SR; Roy, P; Viswanath, G | 1 |
Liu, J; Pope, C | 1 |
4 other study(ies) available for chlorpyrifos and piperidines
Article | Year |
---|---|
Mosquito larvicidal activity of pipernonaline, a piperidine alkaloid derived from long pepper, Piper longum.
Topics: Alkaloids; Animals; Capsicum; Chlorpyrifos; Cholinesterase Reactivators; Culex; Insecticides; Larva; Lethal Dose 50; Malathion; Organothiophosphorus Compounds; Piperidines; Plants, Medicinal | 2000 |
Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.
Topics: Acetylcholine; Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Butyrylcholinesterase; Chlorpyrifos; Cholinesterase Inhibitors; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Female; Humans; Indans; Male; Mice; Mice, Knockout; Neurotoxicity Syndromes; Piperidines; Sesquiterpenes; Synaptic Transmission | 2007 |
Anti-androgenic endocrine disrupting activities of chlorpyrifos and piperophos.
Topics: Androgen Antagonists; Androgens; Animals; Chlorpyrifos; Dose-Response Relationship, Drug; Endocrine Disruptors; Genes, Reporter; Humans; Inhibitory Concentration 50; Luciferases; Male; Mice; NIH 3T3 Cells; Organophosphorus Compounds; Piperidines; Receptors, Androgen; Testosterone; Transfection | 2010 |
The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats.
Topics: Amidohydrolases; Analysis of Variance; Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Chlorpyrifos; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Insecticides; Male; Monoacylglycerol Lipases; Neurotoxicity Syndromes; Paraoxon; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats; Rats, Sprague-Dawley; Time Factors; Tritium | 2015 |